| BMC Pulmonary Medicine | |
| An increased risk of pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema: a meta-analysis | |
| Research | |
| Hangqi Ni1  Yuying Wei1  Qing Wang1  Liuqing Yang1  | |
| [1] Department of Respiratory Medicine, The First Affiliated Hospital, College of Medicine, Zhejiang University, 79 Qingchun Road, 310003, Hangzhou, Zhejiang, People’s Republic of China; | |
| 关键词: CPFE; PH; IPF; COPD; Meta-analysis; | |
| DOI : 10.1186/s12890-023-02425-4 | |
| received in 2022-12-01, accepted in 2023-04-07, 发布年份 2023 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
Background and aimPulmonary hypertension (PH) is a common complication of combined pulmonary fibrosis and emphysema (CPFE). Whether the incidence of PH is increased in CPFE compared with pure pulmonary fibrosis or emphysema remains unclear. This meta-analysis aimed to evaluate the risk of PH in patients with CPFE compared to those with IPF or COPD/emphysema.MethodsWe searched the PubMed, Embase, Cochrane Library, and CNKI databases for relevant studies focusing on the incidence of PH in patients with CPFE and IPF or emphysema. Pooled odds ratios (ORs) and standard mean differences (SMD) with 95% confidence intervals (95% CIs) were used to evaluate the differences in the clinical characteristics presence and severity of PH between patients with CPFE, IPF, or emphysema. The survival impact of PH in patients with CPFE was assessed using hazard ratios (HRs).ResultsA total of 13 eligible studies were included in the meta-analysis, involving 560, 720, and 316 patients with CPFE, IPF, and emphysema, respectively. Patients with CPFE had an increased PH risk with a higher frequency of pulmonary hypertension and higher estimated systolic pulmonary artery pressure (esPAP), compared with those with IPF (OR: 2.66; 95% CI: 1.55-4.57; P < 0.01; SMD: 0.86; 95% CI: 0.52-1.19; P < 0.01) or emphysema (OR: 3.19; 95% CI: 1.42-7.14; P < 0.01; SMD: 0.73; 95% CI: 0.50-0.96; P < 0.01). In addition, the patients with CPFE combined with PH had a poor prognosis than patients with CPFE without PH (HR: 6.16; 95% CI: 2.53–15.03; P < 0.01).ConclusionsOur meta-analysis showed that patients with CPFE were associated with a significantly higher risk of PH compared with those with IPF or emphysema alone. The presence of PH was a poor predictor of mortality.
【 授权许可】
CC BY
© The Author(s) 2023
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202309075592470ZK.pdf | 2591KB | ||
| MediaObjects/12888_2023_4850_MOESM5_ESM.docx | 15KB | Other | |
| 42004_2023_919_Article_IEq176.gif | 1KB | Image | |
| 40517_2023_259_Article_IEq30.gif | 1KB | Image | |
| Fig. 2 | 376KB | Image | |
| 40517_2023_259_Article_IEq53.gif | 1KB | Image | |
| 40517_2023_259_Article_IEq56.gif | 1KB | Image | |
| 40517_2023_259_Article_IEq57.gif | 1KB | Image | |
| MediaObjects/13690_2023_1105_MOESM1_ESM.docx | 32KB | Other | |
| Fig. 1 | 138KB | Image | |
| 40517_2023_259_Article_IEq61.gif | 1KB | Image | |
| 40517_2023_259_Article_IEq62.gif | 1KB | Image |
【 图 表 】
40517_2023_259_Article_IEq62.gif
40517_2023_259_Article_IEq61.gif
Fig. 1
40517_2023_259_Article_IEq57.gif
40517_2023_259_Article_IEq56.gif
40517_2023_259_Article_IEq53.gif
Fig. 2
40517_2023_259_Article_IEq30.gif
42004_2023_919_Article_IEq176.gif
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
- [23]
- [24]
- [25]
- [26]
- [27]
- [28]
- [29]
- [30]
- [31]
- [32]
- [33]
- [34]
- [35]
- [36]
- [37]
- [38]
- [39]
- [40]
- [41]
- [42]
- [43]
- [44]
- [45]
- [46]
- [47]
- [48]
- [49]
- [50]
- [51]
PDF